Elizabeth A. McCracken, MS, CGC

  • Clinical Research Coordinator

Elizabeth McCracken, MS, CGC, joined the Division of Genetic and Genomic Medicine in May of 2006, after graduating from the University of Pittsburgh with a Master’s Degree in Genetic Counseling. Elizabeth completed her undergraduate work at Washington and Jefferson College (W&J), where she graduated with a Bachelor of Science degree in Biology. She is certified by the American Board of Genetic Counselors, a Pennsylvania state licensed genetic counselor and is a member of the National Society of Genetic Counselors. Her clinical interests include inherited metabolic disorders and newborn screening. Elizabeth previously worked as a clinical genetic counselor in the Division of Genetic and Genomic Medicine until 2012 when she transitioned to research working as a clinical research coordinator with clinical trials primarily involving fatty acid oxidation disorders.  As an educator, Elizabeth has provided lectures on genetics and metabolism at the University of Pittsburgh, Graduate School of Public Health and to other University of Pittsburgh graduate students.

Professional and Scientific Society Memberships

  • National Society of Genetic Counselors

Education & Training

  • BA, Biology, Washington and Jefferson College, 2004
  • MS, Genetic Counseling, University of Pittsburgh, 2006

Selected Publications

Vockley J, Charrow J, Ganesh J, Eswara M, Diaz GA, McCracken E, Conway R, Enns GM, Starr J, Wang R, Abdenur JE, Sanchez-de-Toledo J, Marsden DL. Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders. Mol Genet Metab. 2016 Nov;119(3):223-231

Vockley J, Marsden D, McCracken E, DeWard S, Barone A, Hsu K, Kakkis E. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.  Mol Genet Metab. 2015 Sep-Oct;116(1-2):53-60

Schiff M, Mohsen AW, Karunanidhi A, McCracken E, Yeasted R, Vockley J.  Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2013 May;109(1):21-7.

Strehle EM, Yu L, Rosenfeld JA, Donkervoort S, Zhou Y, Chen TJ, Martinez JE, Fan YS, Barbouth D, Zhu H, Vaglio A, Smith R, Stevens CA, Curry CJ, Ladda RL, Fan ZJ, Fox JE, Martin JA, Abdel-Hamid HZ, McCracken EA, McGillivray BC, Masser-Frye D, Huang T. Genotype-phenotype analysis of 4q deletion syndrome: Proposal of a critical region. Am J Med Genet. 2012 Sept; 158A(9): 2139-51.

Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J,Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE. A copy number variation morbidity map of developmental delay. Nat Genet 2011 Aug; 43 (9):838-46.

Ballif BC, Hornor SA, Jenkins E, Madan-Khetarpal S, Surti U, Jackson KE, Asamoah A, Brock PL, Gowans GC, Conway RL, Graham JM Jr, Medne L, Zackai EH, Shaikh TH, Geoghegan J, Selzer RR, Eis PS, Bejjani BA, Shaffer LG. Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2.  Nat Genet. 2007 Sept; 39(9):1071-3.

Weinberg SM, Jenkins EA, Marazita ML, Maher BS. Minor physical anomalies in schizophrenia: a meta-analysis.  Schizophr Res. 2007 Jan; 89(1-3):72-85.

Jenkins EA, Maher BS, Marazita ML, Tarter RE, Ganger JB, Watt-Morse M, Vanyukov MM. Pittsburgh Registry of Infant Multiplets (PRIM): an update. Twin Res Hum Genet. 2006 Dec;9(6):1006-8.

Full Publication List via NIH PubMed »